CellGenTech

Business Services · Japan · 11-50 Employees

View Company Info for Free

Overview

Headquarters

Chiba-dai #101 Inohana, Inohana, Chiba, ...

Phone Number

+81 434414121

Revenue

<$5 Million

Industry

Business Services Research & Development

About CellGenTech

CellGenTech, Inc. specializes in the development of gene therapy and regenerative medicine products, focusing on rare diseases such as familial LCAT deficiency. The company utilizes gene-modified human adipocytes (GMAC) as a platform for ex-vivo gene therapy. Their intended clients include healthcare professionals and patients affected by low HDL cholesterol and LCAT deficiency. CellGenTech is actively engaged in collaborative research and development to advance their innovative therapies.Explore more
SIC Code 87,873NAICS Code 54,541Show more

CellGenTech Org Chart

MA
Japan flag for contact location.

Chief Executive Officer & President

PhoneEmail
HH
Japan flag for contact location.

Auditor

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
Illustration of an envelope

CellGenTech Tech Stack

A closer look at the technologies used by CellGenTech

Top Business Services Companies

Frequently Asked Questions Regarding CellGenTech

What is CellGenTech's official website?
CellGenTech's official website is www.cellgentech.com
What is CellGenTech's Revenue?
CellGenTech's revenue is <$5 Million
What is CellGenTech's SIC code?
CellGenTech's SIC: 87,873
What is CellGenTech's NAICS code?
CellGenTech's NAICS: 54,541
How many employees does CellGenTech have?
CellGenTech has 11-50 employees
What industry does CellGenTech belong to?
CellGenTech is in the industry of: Business Services, Research & Development
What technology does CellGenTech use?
Some of the popular technologies that CellGenTech uses are: Microsoft 365, jQuery, Microsoft Exchange Online
How do I contact CellGenTech?
CellGenTech contact info: Phone number: +81 434414121 Website: www.cellgentech.com
What does CellGenTech do?

CellGenTech, Inc. specializes in the development of gene therapy and regenerative medicine products, focusing on rare diseases such as familial LCAT deficiency. The company utilizes gene-modified human adipocytes (GMAC) as a platform for ex-vivo gene therapy. Their intended clients include healthcare professionals and patients affected by low HDL c... holesterol and LCAT deficiency. CellGenTech is actively engaged in collaborative research and development to advance their innovative therapies.Read More

Is CellGenTech a public company?
CellGenTech is private company therefore does not currently have an official ticker symbol
See more information about CellGenTech

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.